Market Introduction
Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry.
Market Overview and Dynamics
The North America medical collagen market is expected to reach US$ 441.84 million in 2028 from US$ 285.22 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The growth of the North America medical collagen market is attributable to growing applications of collagen in the medical industry, and rising FDA approvals and product launches. However, availability of reliable substitute biomaterials other than medical collagen are hampering the growth of the market.
As collagen is weakly antigenic and biodegradable, it has excellent biocompatibility. Thus, making it a primary resource in medical applications. Collagen is one of the key constituents in cosmetic formulations as it has moisturizing, regenerating, and film-forming properties. Moreover, collagen fillers are widely used in aesthetic medicines. The subcutaneous injection of soluble collagen enhances the quality and density of the skin, thereby repairing dermatological defects. Collagen-based biomaterials have a wide range of applications in vivo and in vitro. Collagen has been widely used to develop synthetic bone graft substitutes for spine, extremities, and dental requirements. Further, collagen scaffolds are developed to mimic and regenerate native tissues and are being rapidly adopted for cartilage repair. Collagen is naturally involved in the wound-healing process, and the use of collagen-based wound dressing offers several advantages for acute and chronic wound closure. Additionally, collagen dressings can control the moisture of the wound either by absorbing or providing moisture. Thus, collagen is widely used in dressings, particles, and flowable scaffolds to treat acute and chronic wounds. This wide range of applications of collagen in the medical industry is driving the growth of the market. Various players operating in the medical collagen market are developing and launching new products to expand their geographic reach and capacity to cater to a large customer base. Thus, constant advancements in products and approvals from regulatory bodies are factors further driving the growth of the medical collagen market.
As per the IRI data, demand for various dietary supplements increased at unprecedented rates owing to the onset of the COVID-19 pandemic in the US. The total supplement sales increased by 6% during the first week of March 2020. Also, due to social distancing practices, consumers are experiencing changes in their daily routines involving grooming and skincare. This has led to an increased demand for nutricosmetics that can be used at home. This is likely to favor the growth of skincare collagen products. Hence, COVID-19 has had a positive impact on the North America medical collagen market.
Key Market Segments
The North America medical collagen market, by source, is segmented into bovine, porcine, and others. The bovine segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR during the forecast period.
The North America medical collagen market, by product, is segmented into gelatine, hydrolysed collagen, native collagen, and others. The gelatine segment held the largest share of the market in 2020 and is expected to register the highest CAGR in the market during the forecast period.
Based on application, the North America medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and others. The wound care segment held the largest share of the market in 2020. However, the bone grafts segment is estimated to register the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the North America medical collagen market are the National Health Surveillance Agency (ANVISA), Food and Drug Administration (FDA), and United Nations Population Fund (UNFPA).
Reasons to buy the report
NORTH AMERICA MEDICAL COLLAGEN MARKET SEGMENTATION
By Source
By Product
By Application
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 285.22 Million |
| Market Size by 2028 | US$ 441.84 Million |
| CAGR (2021 - 2028) | 6.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Source
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Medical Collagen Market is valued at US$ 285.22 Million in 2021, it is projected to reach US$ 441.84 Million by 2028.
As per our report North America Medical Collagen Market, the market size is valued at US$ 285.22 Million in 2021, projecting it to reach US$ 441.84 Million by 2028. This translates to a CAGR of approximately 6.5% during the forecast period.
The North America Medical Collagen Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Medical Collagen Market report:
The North America Medical Collagen Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Medical Collagen Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Medical Collagen Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)